MedPath
TGA Approval

XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle (168143)

168143

XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

January 19, 2010

Medicine

Medicine

Active

Registered

Active Ingredients

levocetirizine dihydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle (168143) - TGA 批准文号 | MedPath